Form D — BTB Therapeutics, Inc.
0002055053-25-000003 · filed Dec 1, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $7,402,704
- Reported amount sold
- $3,402,704
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BTB Therapeutics, Inc.
- CIK
- 2055053
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 26281 WYNDEMERE COURT
ESCONDIDO, California 92026 - Phone
- (858) 945-3733
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Takashi Kiyoizumi · Executive OfficerEscondido, California Find on LinkedIn ↗
-
Nobuhiro Yagi · DirectorEscondido, California Find on LinkedIn ↗
-
Masatoshi Hagiwara · DirectorEscondido, California Find on LinkedIn ↗
-
David Snyder · DirectorEscondido, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗